Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

As a competitive powerlifter, Nathan Zenero has a unique talent for lifting heavy things. He’s also taken on more than a few challenges in his life, including sports injuries and thyroid cancer.

Abbott had been facing supply issues for its Libre devices and said it will ... devices unit trumped estimates on the back of its glucose-monitoring products while smaller units such as nutrition ...

Best glucose monitors from real-time monitoring to flash systems - Get insights into real-time and flash systems for optimal ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor. Abbott had been facing supply issues for its Libre devices and said it will meet the demand ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

A lot of things we commonly hear about diabetes may be based on misconceptions or stereotypes. In fact, nearly 40% of people ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...